- CEO
- Ikuo Takeuchi
- Full Time Employees
- 9,398
- Sector
- Basic Materials
- Industry
- Chemicals - Specialty
- Address
- 1-13-1 Umeda Osaka OS Japan 530-0001
- IPO Date
- Nov 3, 1994
- Business
- Toyobo Co., Ltd. manufactures, processes, and sells advanced materials including films, life science products, environmental and functional materials, and functional textiles worldwide. The company offers packaging films and industrial films such as PET films for liquid crystal displays, optical uses, and synthetic papers; biopharmaceutical products including diagnostic enzymes, pharmaceuticals, medical membranes, hollow fiber membranes for artificial kidneys, and medical tools like nerve regeneration conduits (Nerbridge) and bone regeneration materials (Bonarc); engineering plastics, automotive functional materials, industrial adhesives (VYLON, HARDLEN), photo-functional materials, high-performance fibers, functional filters, nonwoven fabrics (VOLANS), aqua membranes, and airbags; as well as real estate leasing and other businesses. Toyobo operates primarily in Japan, Asia, North America, Europe, and Latin America, targeting industries such as electronics, automotive, healthcare, packaging, and environmental solutions. Founded in 1882 and headquartered in Osaka Umeda Twin Towers South, 1-13-1 Umeda, Kita-ku, Osaka, Japan, the company employs around 9,976 people on a consolidated basis. Recent developments include the establishment of Toyobo MC Corporation as a joint venture with Mitsubishi Corporation in 2023 for functional materials; a June 2025 joint development agreement with DMC Biotechnologies Inc. for sustainable plastic raw materials; an August 2025 company split transferring resin business to Toyobo MC effective October 2025; plans to boost COSMOSHINE SRF film production by 30% at Tsuruga Plant starting fiscal 2026; and a November 2025 absorption-type merger of wholly owned subsidiary TOYOBO STC Co., Ltd. effective April 2026 to streamline trading operations.